A single case reported improvement after several unsuccessful augmentation approaches. It did not establish atomoxetine as a proven alternative to benzodiazepines for panic disorder.
The treatment history
The report concerned a sixty-year-old woman with persistent panic symptoms. Clonazepam initially produced partial improvement, and several antidepressant combinations and augmentation strategies were tried.
The authors described further improvement after atomoxetine was added to a regimen involving clonazepam and paroxetine. The paper presented this as an unusual clinical observation because the role of atomoxetine in panic disorder was uncertain.
Addition is not substitution
The medication was introduced after a long sequence of treatments, rather than compared randomly against clonazepam. Continuing drugs, expectations, symptom fluctuation, and delayed effects could contribute.
The case cannot establish how often this response occurs or identify which patient characteristics predict it. Nor does improvement show that clonazepam had no ongoing contribution.
Practical reading
Preserve which medications remained active and which symptom measures changed. A successful addition should not be rewritten as evidence that a prior medicine was ineffective or that the new medicine can replace it. This report supplies a hypothesis for further research, not a comparative treatment rule or a general safety estimate.
Source paper
Original analysis of the supplied journal article, identified as PMC4662177.
Leave a Reply